Quality antiplatelet drugs are in increasing demand in the ever-changing pharmaceutical field. Ticagrelor, a strong platelet aggregation inhibitor mostly used to lower the chances of heart attacks and strokes in patients with acute coronary syndrome (ACS) or a prior myocardial infarction, is one particularly important medication.